Skip to main content
PIRAMAL PHARMA LIMITED logo

PIRAMAL PHARMA LIMITED — Investor Relations & Filings

Ticker · PPLPHARMA ISIN · INE0DK501011 LEI · 3358006D6AL7PZ4U9T51 BSE.NS Manufacturing
Open in API
Filings indexed 365 across all filing types
Latest filing 2026-03-02 Regulatory Filings
Country IN India
Listing BSE.NS PPLPHARMA

About PIRAMAL PHARMA LIMITED

https://www.piramalpharma.com/

Piramal Pharma Limited provides a broad range of products and services across the drug lifecycle through three main business segments: Piramal Pharma Solutions, Piramal Critical Care, and Consumer Healthcare. Piramal Pharma Solutions operates as an integrated Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from drug discovery and development to commercial manufacturing of APIs and formulations. Piramal Critical Care focuses on complex hospital generics, holding a significant global market share in inhalation anesthetics, including Sevoflurane and Isoflurane, as well as injectable anesthesia and pain management therapies. The Consumer Healthcare division manages a diverse portfolio of over-the-counter brands such as Saridon, Lacto Calamine, and Tetmosol. The company leverages an extensive global manufacturing network to deliver specialized healthcare solutions worldwide.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing about the schedule of an Analyst/Institutional Investor Meeting. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and provides details of the meeting date, nature, and venue. There is no financial data, no report attached or published, and no detailed presentation or analysis included. The document is essentially an announcement of a meeting schedule, not a report or transcript. Given the content and length (1593 characters), it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-03-02 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 24th February 2026, addressed to stock exchanges BSE and NSE. It provides contact details of Key Managerial Personnel (KMP) as required under Regulation 30(5) of the SEBI Listing Regulations. The content is a regulatory compliance disclosure about KMP contact information for materiality determination and disclosures. It does not contain financial data, report content, or detailed management discussion. The document length is only 1594 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-02-24 English
Action(s) taken or orders passed
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the revocation of a closure direction for the company's manufacturing site. It references regulatory compliance under SEBI Listing Regulations and communicates an operational update about the Dahej site. The document is brief (1810 characters) and does not contain financial data, audit information, or detailed report content. It is an announcement of a regulatory or operational event rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-14 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about a US FDA inspection and issuance of Form-483 with observations. It is an announcement of a regulatory event related to compliance and inspection results, not a financial report or detailed audit report. The document is short (1769 characters) and serves as an informational announcement to stock exchanges and shareholders. It does not contain financial data, management discussion, or detailed audit findings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-14 English
Action(s) taken or orders passed
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, 2015. It informs about an interim environmental damage compensation imposed by a regulatory authority (Gujarat Pollution Control Board) related to a plant closure. The document does not contain financial statements or detailed financial analysis but is a regulatory announcement about an environmental and compliance issue. It is not an annual or interim report, audit report, or earnings release. It is not a voting result, capital update, or management change. The document fits best under Regulatory Filings (RNS) as it is a compliance disclosure under SEBI regulations about a material event affecting the company.
2026-02-11 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release dated 5th February 2026 from Piramal Pharma Limited announcing a collaboration agreement between its subsidiary Piramal Critical Care Inc and Blue-Zone Technologies Ltd. The content focuses on the partnership to capture, collect, and recycle waste anaesthetic gases, describing the business collaboration, technology, and strategic goals. There are no financial statements, regulatory filings, voting results, or management changes discussed. The document is a corporate announcement about a business collaboration, not a financial report, regulatory filing, or shareholder meeting material. Therefore, it best fits the category of a general regulatory announcement or miscellaneous corporate news, which falls under Regulatory Filings (RNS). The document length is 6915 characters, which is sufficient for a full press release but does not contain financial data or detailed report content. Hence, the classification is RNS with high confidence.
2026-02-05 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.